Analyst Ratings For AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)
Today, B. Riley initiated coverage on AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) with a Buy with a price target of $9.00.
There are 6 Buy Ratings, 1 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.
The current consensus rating on AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) is Buy with a consensus target price of $8.3333 per share, a potential 109.38% upside.
Some recent analyst ratings include
- 10/23/2018-AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) has coverage initiated with a Buy ➝ Buy rating and $9.00 price target
- 10/15/2018-AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) had its Hold rating reiterated by Oppenheimer
- 10/15/2018-AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) gets upgraded to Buy by Jefferies Financial Group with a price target of $8.00
- 10/10/2018-AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) had its Buy ➝ Buy rating reiterated by LADENBURG THALM/SH SH with a $10.00 price target
- On 10/15/2018 Badri N Dasu, Insider, sold 28,351 with an average share price of $5.00 per share and the total transaction amounting to $141,755.00.
- On 9/24/2018 Lawrence G Hamel, Insider, sold 6,953 with an average share price of $4.50 per share and the total transaction amounting to $31,288.50.
- On 8/7/2018 Mark G Edwards, Director, bought 5,300 with an average share price of $2.84 per share and the total transaction amounting to $15,052.00.
- On 8/7/2018 Vincent J. Angotti, CEO, bought 10,000 with an average share price of $2.90 per share and the total transaction amounting to $29,000.00.
- On 8/6/2018 Pamela P. Palmer, Insider, bought 37,000 with an average share price of $2.75 per share and the total transaction amounting to $101,750.00.
- On 8/6/2018 Raffi Asadorian, CFO, bought 5,000 with an average share price of $2.75 per share and the total transaction amounting to $13,750.00.
- On 6/5/2018 Mark G Edwards, Director, bought 5,000 with an average share price of $3.35 per share and the total transaction amounting to $16,750.00.
Recent Trading Activity for AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)
Shares of AcelRx Pharmaceuticals Inc closed the previous trading session at 3.98 up +0.23 6.13% with 3.92 shares trading hands.